Ahmet Yanik
Ahmet Yanik has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Faruk Boyacı
Department of Cardiology, Samsun University, Samsun Education and Research Hospital, Samsun, Türkiye
6 shared publications - Mustafa Kursat Sahin
Department of Family Medicine, Faculty of Medicine, Ondokuz Mayıs University, Samsun, Turkey
5 shared publications - Gökhan Aksan
Department of Cardiology, İstanbul University, İstanbul Faculty of Medicine, İstanbul, Türkiye
4 shared publications - Korhan Soylu
Ondokuz Mayis University Samsun Turkey
3 shared publications - Murat Akcay
Department of Cardiology, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey.
3 shared publications - Berkant Ozturk
Department of Cardiology, Faculty of Medicine, Samsun University, Samsun 55080, Türkiye
2 shared publications
Latest Publications
- Open Access
- 27 June 2026
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 26 (1)
The COPD-augmented R₂CHA₂DS₂-VA score: development and internal assessment for predicting one-year outcomes after transcatheter aortic valve implantation
Existing CHA₂DS₂-VASc-based scores incompletely capture the prognostic impact of chronic obstructive pulmonary disease (COPD) and of graded renal dysfunction in patients undergoing transcatheter aortic valve implantation (TAVI). We acknowledge that the score's development in a high-risk, high-comorbidity cohort may produce optimistic performance estimates that require attenuation through external validation. We aimed to develop a novel COPD-augmented R₂CHA₂DS₂-VA (COPD-R₂CHA₂DS₂-VA) score that systematically integrates quantitative renal function and COPD, and to internally assess its discriminative performance for one-year all-cause mortality and major adverse cardiovascular events (MACE). In this single-center, retrospective cohort study, 622 consecutive patients undergoing TAVI for severe aortic stenosis (2018-2024) were analyzed. The COPD-R₂CHA₂DS₂-VA score was constructed as a prespecified clinical tool by augmenting the R₂CHA₂DS₂-VA framework with COPD (1 point) and refining renal dysfunction into two graded estimated glomerular filtration rate strata (eGFR 30-59 mL/min/1.73 m²: 1 point; eGFR < 30: 2 points). Discriminative performance was evaluated using receiver operating characteristic curve analysis with bootstrap internal validation (2,000 resamples) and compared with established CHA₂DS₂-VASc-based scores. Multivariable logistic regression assessed the independent prognostic value of the score treated as a continuous variable. The COPD-R₂CHA₂DS₂-VA score demonstrated encouraging discriminative ability for one-year all-cause mortality (apparent area under the curve [AUC] 0.946, 95% CI 0.926-0.971). As a prespecified tool with fixed component weights, bootstrap internal validation confirmed negligible optimism (mean optimism - 0.00014), with bias-corrected AUC identical to the apparent value. The addition of COPD significantly improved mortality discrimination over the R₂CHA₂DS₂-VA score (ΔAUC + 0.033, p = 0.0001). For one-year MACE, the apparent AUC was 0.806 (95% CI 0.765-0.852); the addition of COPD did not significantly enhance MACE discrimination (ΔAUC + 0.001, p = 0.853). In multivariable analysis, each one‑point increase in the COPD-R₂CHA₂DS₂-VA score was independently associated with 3.52-fold higher odds of one-year mortality (95% CI 2.45-5.06, p < 0.001) and 2.02-fold higher odds of MACE (95% CI 1.67-2.46, p < 0.001). The bias-corrected AUC of the full multivariable model was 0.973 (95% CI 0.962-0.984) for mortality and 0.795 (95% CI 0.752-0.841) for MACE. The COPD-R₂CHA₂DS₂-VA score demonstrated encouraging discriminative ability for one-year all-cause mortality after TAVI in this single-center development cohort (apparent AUC 0.946). However, this high discriminative performance is likely influenced by the elevated comorbidity burden in our cohort and the single-center design, and should be interpreted as an upper-bound estimate. The addition of COPD provides a statistically significant but clinically modest incremental improvement for mortality (ΔAUC + 0.033, p = 0.0001), with no significant enhancement for MACE (ΔAUC + 0.001, p = 0.853). These findings are preliminary and hypothesis-generating; urgent external validation in diverse, prospective cohorts is essential before any clinical application can be considered. At present, this score should be regarded as a development-phase, hypothesis-generating tool that complements rather than replaces guideline-recommended instruments such as STS-PROM and EuroSCORE II. The score's clinical utility remains unproven.
- 27 June 2026
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 26 (1)
Open AccessThe COPD-augmented R₂CHA₂DS₂-VA score: development and internal assessment for predicting one-year outcomes after transcatheter aortic valve implantation
Existing CHA₂DS₂-VASc-based scores incompletely capture the prognostic impact of chronic obstructive pulmonary disease (COPD) and of graded renal dysfunction in patients undergoing transcatheter aortic valve implantation (TAVI). We acknowledge that the score's development in a high-risk, high-comorbidity cohort may produce optimistic performance estimates that require attenuation through external validation. We aimed to develop a novel COPD-augmented R₂CHA₂DS₂-VA (COPD-R₂CHA₂DS₂-VA) score that systematically integrates quantitative renal function and COPD, and to internally assess its discriminative performance for one-year all-cause mortality and major adverse cardiovascular events (MACE). In this single-center, retrospective cohort study, 622 consecutive patients undergoing TAVI for severe aortic stenosis (2018-2024) were analyzed. The COPD-R₂CHA₂DS₂-VA score was constructed as a prespecified clinical tool by augmenting the R₂CHA₂DS₂-VA framework with COPD (1 point) and refining renal dysfunction into two graded estimated glomerular filtration rate strata (eGFR 30-59 mL/min/1.73 m²: 1 point; eGFR < 30: 2 points). Discriminative performance was evaluated using receiver operating characteristic curve analysis with bootstrap internal validation (2,000 resamples) and compared with established CHA₂DS₂-VASc-based scores. Multivariable logistic regression assessed the independent prognostic value of the score treated as a continuous variable. The COPD-R₂CHA₂DS₂-VA score demonstrated encouraging discriminative ability for one-year all-cause mortality (apparent area under the curve [AUC] 0.946, 95% CI 0.926-0.971). As a prespecified tool with fixed component weights, bootstrap internal validation confirmed negligible optimism (mean optimism - 0.00014), with bias-corrected AUC identical to the apparent value. The addition of COPD significantly improved mortality discrimination over the R₂CHA₂DS₂-VA score (ΔAUC + 0.033, p = 0.0001). For one-year MACE, the apparent AUC was 0.806 (95% CI 0.765-0.852); the addition of COPD did not significantly enhance MACE discrimination (ΔAUC + 0.001, p = 0.853). In multivariable analysis, each one‑point increase in the COPD-R₂CHA₂DS₂-VA score was independently associated with 3.52-fold higher odds of one-year mortality (95% CI 2.45-5.06, p < 0.001) and 2.02-fold higher odds of MACE (95% CI 1.67-2.46, p < 0.001). The bias-corrected AUC of the full multivariable model was 0.973 (95% CI 0.962-0.984) for mortality and 0.795 (95% CI 0.752-0.841) for MACE. The COPD-R₂CHA₂DS₂-VA score demonstrated encouraging discriminative ability for one-year all-cause mortality after TAVI in this single-center development cohort (apparent AUC 0.946). However, this high discriminative performance is likely influenced by the elevated comorbidity burden in our cohort and the single-center design, and should be interpreted as an upper-bound estimate. The addition of COPD provides a statistically significant but clinically modest incremental improvement for mortality (ΔAUC + 0.033, p = 0.0001), with no significant enhancement for MACE (ΔAUC + 0.001, p = 0.853). These findings are preliminary and hypothesis-generating; urgent external validation in diverse, prospective cohorts is essential before any clinical application can be considered. At present, this score should be regarded as a development-phase, hypothesis-generating tool that complements rather than replaces guideline-recommended instruments such as STS-PROM and EuroSCORE II. The score's clinical utility remains unproven.
- Open Access
- 7 December 2025
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 26 (1)
The association between the monocyte-to-HDL cholesterol ratio and coronary collateral circulation in patients with chronic total occlusion
Coronary collateral circulation (CCC) plays a crucial role in preserving myocardial perfusion in patients with chronic total occlusion (CTO) of the coronar
- 7 December 2025
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 26 (1)
Open AccessThe association between the monocyte-to-HDL cholesterol ratio and coronary collateral circulation in patients with chronic total occlusion
Coronary collateral circulation (CCC) plays a crucial role in preserving myocardial perfusion in patients with chronic total occlusion (CTO) of the coronar
- Open Access
Predictors of Length of Stay in Hospital After Transcatheter Aortic Valve Replacement: Impact of Naples Prognostic Score
Background and Objectives: Preoperative systemic inflammation and nutritional status are known to affect prognosis and length of hospital stay (LoS) in patients undergoing transcatheter aortic valve replacement (TAVR). The Naples Prognostic Score (NPS) is a simple and effective scoring system that assesses both nutrition and inflammation, and has been shown to predict prognosis in various clinical settings. We aimed to determine the effect of NPS on LoS in patients undergoing TAVR. Materials and Methods: A total of 405 patients who underwent TAVR were retrospectively divided into two groups based on length of stay: early discharge (LoS ≤ 3 days) and late discharge (LoS > 3 days). The NPS was calculated prior to the TAVR procedure. Results: In the late discharge group (n = 164, 40.6%), patients were found to have significantly higher values for age, NYHA functional class, STS risk score, systolic pulmonary artery pressure, white blood cell count, neutrophil count, monocyte count, creatinine, glucose, NLR, rate of surgical access site, incidence of major/minor access site and structural complications, myocardial infarction, cerebrovascular events, acute kidney injury, major bleeding, blood transfusion, pacemaker implantation, and elevated NPS (p < 0.05). When independent risk factors for late discharge were evaluated, in addition to reduced eGFR, surgical closure of the access site, history of cerebrovascular events, need for pacemaker implantation, and blood transfusion, a high Naples Prognostic Score was also identified as an independent risk factor for prolonged hospital stay after TAVR in the multivariate logistic regression analysis (p < 0.05). Conclusions: A high Naples Prognostic Score (NPS), which reflects systemic inflammation and nutritional status, is associated with delayed hospital discharge and is an independent risk factor in patients undergoing TAVR.
Open AccessPredictors of Length of Stay in Hospital After Transcatheter Aortic Valve Replacement: Impact of Naples Prognostic Score
Background and Objectives: Preoperative systemic inflammation and nutritional status are known to affect prognosis and length of hospital stay (LoS) in patients undergoing transcatheter aortic valve replacement (TAVR). The Naples Prognostic Score (NPS) is a simple and effective scoring system that assesses both nutrition and inflammation, and has been shown to predict prognosis in various clinical settings. We aimed to determine the effect of NPS on LoS in patients undergoing TAVR. Materials and Methods: A total of 405 patients who underwent TAVR were retrospectively divided into two groups based on length of stay: early discharge (LoS ≤ 3 days) and late discharge (LoS > 3 days). The NPS was calculated prior to the TAVR procedure. Results: In the late discharge group (n = 164, 40.6%), patients were found to have significantly higher values for age, NYHA functional class, STS risk score, systolic pulmonary artery pressure, white blood cell count, neutrophil count, monocyte count, creatinine, glucose, NLR, rate of surgical access site, incidence of major/minor access site and structural complications, myocardial infarction, cerebrovascular events, acute kidney injury, major bleeding, blood transfusion, pacemaker implantation, and elevated NPS (p < 0.05). When independent risk factors for late discharge were evaluated, in addition to reduced eGFR, surgical closure of the access site, history of cerebrovascular events, need for pacemaker implantation, and blood transfusion, a high Naples Prognostic Score was also identified as an independent risk factor for prolonged hospital stay after TAVR in the multivariate logistic regression analysis (p < 0.05). Conclusions: A high Naples Prognostic Score (NPS), which reflects systemic inflammation and nutritional status, is associated with delayed hospital discharge and is an independent risk factor in patients undergoing TAVR.
- 14 March 2024
- Published by Konuralp Medical Journal in Konuralp Tip Dergisi
- Vol. 16 (1) , 46-53
Comparison of CHA₂DS₂VASc and R₂CHA₂DS₂VASc score estimation of in-hospital mortality among COVID-19 patients
Objectives: This study aims to compare of CHA₂DS₂VASc and R₂CHA₂DS₂VASc score estimation of in-hospital mortality among COVID-19 patients and find a new scoring system that can better predict the hospital mortality by adding some laboratory parameters to the CHA₂DS₂VASc and R₂CHA₂DS₂VASc scores. Methods: This is a cross-sectional study. A total of 1076 COVID-19 patients with confirmed COVID-19 PCR tests were included from September 2020 to March 2021. Age, sex, comorbidity, laboratory, survival times, and death status of the patients were recorded. The scores CHA₂DS₂VASc and R₂CHA₂DS₂VASc of each patient were calculated. A new mortality prediction score was created to establish the most effective model with logistic regression analysis, including laboratory values. Results: Of the 1076 patients hospitalized for COVID-19, 15.1% died, while 84.9% survived. There was no significant difference between the two groups in sex. All comorbidities were significantly higher in the deceased than in the survivors (p
- 14 March 2024
- Published by Konuralp Medical Journal in Konuralp Tip Dergisi
- Vol. 16 (1) , 46-53
Comparison of CHA₂DS₂VASc and R₂CHA₂DS₂VASc score estimation of in-hospital mortality among COVID-19 patients
Objectives: This study aims to compare of CHA₂DS₂VASc and R₂CHA₂DS₂VASc score estimation of in-hospital mortality among COVID-19 patients and find a new scoring system that can better predict the hospital mortality by adding some laboratory parameters to the CHA₂DS₂VASc and R₂CHA₂DS₂VASc scores. Methods: This is a cross-sectional study. A total of 1076 COVID-19 patients with confirmed COVID-19 PCR tests were included from September 2020 to March 2021. Age, sex, comorbidity, laboratory, survival times, and death status of the patients were recorded. The scores CHA₂DS₂VASc and R₂CHA₂DS₂VASc of each patient were calculated. A new mortality prediction score was created to establish the most effective model with logistic regression analysis, including laboratory values. Results: Of the 1076 patients hospitalized for COVID-19, 15.1% died, while 84.9% survived. There was no significant difference between the two groups in sex. All comorbidities were significantly higher in the deceased than in the survivors (p
- Open Access
- 1 April 2022
- Published by Wiley in Journal of Arrhythmia
- Vol. 38 (3) , 353-362
The predictive value of galectin‐3 levels on left atrial low voltage areas assessed by high‐density mapping in patients with paroxysmal atrial fibrillation
Aims: Galectin-3 is an inflammation biomarker that is associated with atrial fibrosis and plays a role in the development of atrial fibrillation (AF). Low voltage areas (LVAs) identified using an electroanatomical mapping system represent the presence of fibrotic tissue. The present study aimed to determine the relationship between coronary sinus (CS) serum sampling of galectin-3 levels and the presence and extent of LVA in patients with paroxysmal AF. Methods: A total of 115 consecutive paroxysmal AF patients underwent pulmonary vein isolation (PVI) included prospectively in the study. Voltage mapping was performed before PVI during sinus rhythm guided by multipolar high-density mapping catheter and LVAs were defined as regions where bipolar peak to peak voltage was <0.5 mV. Galectin-3 levels were measured via enzyme-linked immunosorbent assay. Results: CS serum sampling of galectin-3 levels was significantly higher in paroxysmal AF patients with LVA than those without LVA (16.5 +/- 3.7 ng/ml vs. 10.2 +/- 2.7 ng/ml, respectively, p < .001). CS serum sampling of galectin-3 levels was significantly higher in paroxysmal AF patients with moderate and severe LVA than in paroxysmal AF patients with mild LVA (17 +/- 3.5 ng/ml and 20.1 +/- 1.3 ng/ml vs. 13.3 +/- 2.3 ng/ml, respectively, p = .002). In the multivariate analysis female gender (odds ratio [OR] = 7.537, 95% confidence interval [CI]: 1.011-56.195; p = .049), left atrium volume (OR = 1.326, 95% CI: 1.052-1.67; p = .017), and CS serum sampling of galectin-3 levels (OR = 1.704, 95% CI: 1.169-2.483; p = .006) were significant and independent predictors for LVAs. Conclusion: In this study, we found that the CS serum sampling of galectin-3 levels increased with the extent of LVA and was an independent predictor for the presence of LVA.
- 1 April 2022
- Published by Wiley in Journal of Arrhythmia
- Vol. 38 (3) , 353-362
Open AccessThe predictive value of galectin‐3 levels on left atrial low voltage areas assessed by high‐density mapping in patients with paroxysmal atrial fibrillation
Aims: Galectin-3 is an inflammation biomarker that is associated with atrial fibrosis and plays a role in the development of atrial fibrillation (AF). Low voltage areas (LVAs) identified using an electroanatomical mapping system represent the presence of fibrotic tissue. The present study aimed to determine the relationship between coronary sinus (CS) serum sampling of galectin-3 levels and the presence and extent of LVA in patients with paroxysmal AF. Methods: A total of 115 consecutive paroxysmal AF patients underwent pulmonary vein isolation (PVI) included prospectively in the study. Voltage mapping was performed before PVI during sinus rhythm guided by multipolar high-density mapping catheter and LVAs were defined as regions where bipolar peak to peak voltage was <0.5 mV. Galectin-3 levels were measured via enzyme-linked immunosorbent assay. Results: CS serum sampling of galectin-3 levels was significantly higher in paroxysmal AF patients with LVA than those without LVA (16.5 +/- 3.7 ng/ml vs. 10.2 +/- 2.7 ng/ml, respectively, p < .001). CS serum sampling of galectin-3 levels was significantly higher in paroxysmal AF patients with moderate and severe LVA than in paroxysmal AF patients with mild LVA (17 +/- 3.5 ng/ml and 20.1 +/- 1.3 ng/ml vs. 13.3 +/- 2.3 ng/ml, respectively, p = .002). In the multivariate analysis female gender (odds ratio [OR] = 7.537, 95% confidence interval [CI]: 1.011-56.195; p = .049), left atrium volume (OR = 1.326, 95% CI: 1.052-1.67; p = .017), and CS serum sampling of galectin-3 levels (OR = 1.704, 95% CI: 1.169-2.483; p = .006) were significant and independent predictors for LVAs. Conclusion: In this study, we found that the CS serum sampling of galectin-3 levels increased with the extent of LVA and was an independent predictor for the presence of LVA.
- Open Access
- 4 March 2021
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 25 (3) , 196-204
Real-life data of major and minor bleeding events with direct oral anticoagulants in the one-year follow-up period: The NOAC-TURK study
This study aimed to evaluate the safety of direct oral anticoagulants (DOACs) in patients with non-valvular atrial fibrillation (NVAF) during daily clinical practice. This was a prospective study conducted between January 01, 2016, and April 01, 2017, in patients aged ≥18 years with a diagnosis of NVAF. We performed the study in 9 clinical centers from different regions of Turkey, and the mean follow-up period was 12+2 months. We investigated major and minor bleeding events of DOAC. A total of 1807 patients with NVAF were enrolled. The mean age of the patients was 73.6±10.2 years, CHA2DS2-VASc score was 3.6±1.4, and HAS-BLED score was 2±1.2. The most frequently prescribed DOAC was dabigatran 110 mg bid in 409 (22.6%) patients. The patients on apixaban 2.5 mg bid were older (p<0.001). Patients on rivaroxaban 15 mg od also had a higher prevalence of chronic renal failure, 46 (16.7%) patients. A total of 205 (11.4%) bleeding events were observed; among these, 34 (1.9%) patients had major bleeding and 171 (9.4%) patients had minor bleeding. The major and minor bleeding events were 2/273 (0.7%) and 30/273 (10.9%) in patients receiving dabigatran 150 mg bid, 13/409 (3%) and 44/409 (10.7%) in patients receiving dabigatran 110 mg bid, 4/385 (1%) and 42/385 (10.9%) in patients receiving rivaroxaban 20 mg od, 8/276 (2.9%) and 27/276 (9.7%) in patients receiving rivaroxaban 15 mg od, 3/308 (0.9%) and 14/308 (4.5%) in patients receiving apixaban 5 mg bid, 4/156 (2.5%) and 14/156 (9%) in patients receiving apixaban 2.5 mg bid, respectively. The total bleeding events were 17 (5.6%) in patients receiving apixaban 5 mg, less than those receiving other DOACs. On multivariate analyses, rivaroxaban 20 mg od (p=0.002), ATRIA and HAS-BLED scores, and peripheral artery disease were independent indicators of bleeding. The most frequent location of major bleeding was the gastrointestinal system (GIS) [17 (0.9%) patients], and the most frequent location of minor bleeding was the gingiva [45 (2.5%) patients]. This study showed that similar results as the previous real-life study; however, we had some different results, such as the GIS tract bleeding was more frequent in patients receiving dabigatran 110 mg bid. The major and intracranial bleeding events were similar for different DOACs; and among DOACs, only rivaroxaban 20 mg od was associated with a high risk of bleeding.
- 4 March 2021
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 25 (3) , 196-204
Open AccessReal-life data of major and minor bleeding events with direct oral anticoagulants in the one-year follow-up period: The NOAC-TURK study
This study aimed to evaluate the safety of direct oral anticoagulants (DOACs) in patients with non-valvular atrial fibrillation (NVAF) during daily clinical practice. This was a prospective study conducted between January 01, 2016, and April 01, 2017, in patients aged ≥18 years with a diagnosis of NVAF. We performed the study in 9 clinical centers from different regions of Turkey, and the mean follow-up period was 12+2 months. We investigated major and minor bleeding events of DOAC. A total of 1807 patients with NVAF were enrolled. The mean age of the patients was 73.6±10.2 years, CHA2DS2-VASc score was 3.6±1.4, and HAS-BLED score was 2±1.2. The most frequently prescribed DOAC was dabigatran 110 mg bid in 409 (22.6%) patients. The patients on apixaban 2.5 mg bid were older (p<0.001). Patients on rivaroxaban 15 mg od also had a higher prevalence of chronic renal failure, 46 (16.7%) patients. A total of 205 (11.4%) bleeding events were observed; among these, 34 (1.9%) patients had major bleeding and 171 (9.4%) patients had minor bleeding. The major and minor bleeding events were 2/273 (0.7%) and 30/273 (10.9%) in patients receiving dabigatran 150 mg bid, 13/409 (3%) and 44/409 (10.7%) in patients receiving dabigatran 110 mg bid, 4/385 (1%) and 42/385 (10.9%) in patients receiving rivaroxaban 20 mg od, 8/276 (2.9%) and 27/276 (9.7%) in patients receiving rivaroxaban 15 mg od, 3/308 (0.9%) and 14/308 (4.5%) in patients receiving apixaban 5 mg bid, 4/156 (2.5%) and 14/156 (9%) in patients receiving apixaban 2.5 mg bid, respectively. The total bleeding events were 17 (5.6%) in patients receiving apixaban 5 mg, less than those receiving other DOACs. On multivariate analyses, rivaroxaban 20 mg od (p=0.002), ATRIA and HAS-BLED scores, and peripheral artery disease were independent indicators of bleeding. The most frequent location of major bleeding was the gastrointestinal system (GIS) [17 (0.9%) patients], and the most frequent location of minor bleeding was the gingiva [45 (2.5%) patients]. This study showed that similar results as the previous real-life study; however, we had some different results, such as the GIS tract bleeding was more frequent in patients receiving dabigatran 110 mg bid. The major and intracranial bleeding events were similar for different DOACs; and among DOACs, only rivaroxaban 20 mg od was associated with a high risk of bleeding.
- Open Access
- 1 January 2021
- Published by AVES YAYINCILIK A.Ş. in The Eurasian Journal of Medicine
- Vol. 53 (2) , 90-95
Assessment of Arterial Stiffness with Cardio-Ankle Vascular Index in Patients with Mitral Annular Calcification
Objective: Arterial stiffness is related to arteriolosclerotic diseases and is a marker of adverse cardiovascular events. Mitral annular calcification (MAC) is progressive calcium deposition on the posterior and inferior mitral annulus and is associated with atherosclerotic cardiovascular diseases. Cardio-ankle vascular index (CAVI) is a measurement technique used to estimate the degree of arterial stiffness without effect from blood pressure. The aim of this study is to research arterial stiffness using CAVI in patients with MAC. Materials and Methods: The study was cross-sectional and observational and included 98 patients with MAC confirmed by echocardiography who referred to the cardiology clinics and met study inclusion criteria and 38 controls without MAC. CAVI measurements were obtained by using the Vascular Screening System VaSera VS-1000 (Fukuda Denshi, Tokyo, Japan) device. Results: The two groups were similar in terms of demographic characteristics, including age, sex, hypertension, coronary artery disease, body surface area, and smoking (P > .05). Left atrial volume index was significantly higher in patients with MAC compared with the control group (P < .001). Right arm CAVI, left arm CAVI, and mean CAVI were significantly higher in the MAC group than the control group (P = .037, P = .005, and P = .014, respectively) and increased with MAC severity. There was a significant positive correlation between mean CAVI and MAC grade (r = 0.278, P = .001). Also, when ankle-brachial index (ABI) was measured with CAVI, left and right extremity ABI values were significantly lower in patients with MAC (P = .017 and P = .005, respectively). Conclusion: CAVI increased in all patients with MAC and associated with increasing grade of calcification.
- 1 January 2021
- Published by AVES YAYINCILIK A.Ş. in The Eurasian Journal of Medicine
- Vol. 53 (2) , 90-95
Open AccessAssessment of Arterial Stiffness with Cardio-Ankle Vascular Index in Patients with Mitral Annular Calcification
Objective: Arterial stiffness is related to arteriolosclerotic diseases and is a marker of adverse cardiovascular events. Mitral annular calcification (MAC) is progressive calcium deposition on the posterior and inferior mitral annulus and is associated with atherosclerotic cardiovascular diseases. Cardio-ankle vascular index (CAVI) is a measurement technique used to estimate the degree of arterial stiffness without effect from blood pressure. The aim of this study is to research arterial stiffness using CAVI in patients with MAC. Materials and Methods: The study was cross-sectional and observational and included 98 patients with MAC confirmed by echocardiography who referred to the cardiology clinics and met study inclusion criteria and 38 controls without MAC. CAVI measurements were obtained by using the Vascular Screening System VaSera VS-1000 (Fukuda Denshi, Tokyo, Japan) device. Results: The two groups were similar in terms of demographic characteristics, including age, sex, hypertension, coronary artery disease, body surface area, and smoking (P > .05). Left atrial volume index was significantly higher in patients with MAC compared with the control group (P < .001). Right arm CAVI, left arm CAVI, and mean CAVI were significantly higher in the MAC group than the control group (P = .037, P = .005, and P = .014, respectively) and increased with MAC severity. There was a significant positive correlation between mean CAVI and MAC grade (r = 0.278, P = .001). Also, when ankle-brachial index (ABI) was measured with CAVI, left and right extremity ABI values were significantly lower in patients with MAC (P = .017 and P = .005, respectively). Conclusion: CAVI increased in all patients with MAC and associated with increasing grade of calcification.
- 29 April 2020
- Published by Harran Universitesi Tip Fakultesi Dergisi in Harran Üniversitesi Tıp Fakültesi Dergisi
- Vol. 17 (1) , 149-152
Üç Boyutlu Elektroanatomik Haritalama Sistemi İle Sağ Atriyal Apendiks Taşikardisinin Ablasyonu: Nadir Bir Vaka
Atrial tachycardias (AT) originating from right atrial appendage (RAA) are quite rare among focal atrial tachycardias. A 38-year-old female patient presented to the emergency room complaining of palpitations and dizziness. Electrocardiography (ECG) showed regular narrow QRS complex tachycardia with a ventricular rate of 150 bpm. The patient had frequent episodes of palpitations for 5 years. Considering the ensuing tachycardiomyopathy under medical treatment, electrophysiological study (EPS) and ablation procedure was planned after having informed consent. During isoproterenol infusion (1-4 mcg/min), a sustained tachycardia with narrow QRS complex was induced. Diagnostic electrophysiological findings were consistent with AT. During tachycardia, by using a three-dimensional (3D) electroanatomic mapping system, simultaneous anatomical and activation mapping was performed with a quadripolar 3.5mm cooled-tip Thermocool Smarttouch bi-directional navigation catheter. Activation mapping demonstrated that the earliest endocardial activation site was basal portion of the RAA where the local electrogram was 104 msn prior to the Cs reference signal during tachycardia which is spreading in a centrifugal fashion. Impedance-controlled radiofrequency ablation (RF) ablation (35 W, 42° C, 5-10 g of contact force) was performed at the earliest site and tachycardia terminated in 10 seconds. No AT observed during the waiting period of 30 min after RF ablation.
- 29 April 2020
- Published by Harran Universitesi Tip Fakultesi Dergisi in Harran Üniversitesi Tıp Fakültesi Dergisi
- Vol. 17 (1) , 149-152
Üç Boyutlu Elektroanatomik Haritalama Sistemi İle Sağ Atriyal Apendiks Taşikardisinin Ablasyonu: Nadir Bir Vaka
Atrial tachycardias (AT) originating from right atrial appendage (RAA) are quite rare among focal atrial tachycardias. A 38-year-old female patient presented to the emergency room complaining of palpitations and dizziness. Electrocardiography (ECG) showed regular narrow QRS complex tachycardia with a ventricular rate of 150 bpm. The patient had frequent episodes of palpitations for 5 years. Considering the ensuing tachycardiomyopathy under medical treatment, electrophysiological study (EPS) and ablation procedure was planned after having informed consent. During isoproterenol infusion (1-4 mcg/min), a sustained tachycardia with narrow QRS complex was induced. Diagnostic electrophysiological findings were consistent with AT. During tachycardia, by using a three-dimensional (3D) electroanatomic mapping system, simultaneous anatomical and activation mapping was performed with a quadripolar 3.5mm cooled-tip Thermocool Smarttouch bi-directional navigation catheter. Activation mapping demonstrated that the earliest endocardial activation site was basal portion of the RAA where the local electrogram was 104 msn prior to the Cs reference signal during tachycardia which is spreading in a centrifugal fashion. Impedance-controlled radiofrequency ablation (RF) ablation (35 W, 42° C, 5-10 g of contact force) was performed at the earliest site and tachycardia terminated in 10 seconds. No AT observed during the waiting period of 30 min after RF ablation.
- Open Access
- 1 January 2015
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 21, 2116-2124
Exercise-Induced Repolarization Changes in Patients with Isolated Myocardial Bridging
Although myocardial bridging (MB) is defined as an angiographic phenomenon with a benign course, it has also been associated with adverse cardiovascular events. The effects of exercise on myocardial repolarization in patients with MB were tested in this study, with Tp-e and Tp-e/QT repolarization indexes. A total of 50 patients in whom isolated MB was diagnosed at coronary angiography (CAG) (Group I) and 48 patients with normal CAG results (Group II) were included in this study. The participants underwent treadmill exercise stress testing according to the Bruce protocol. QT dispersion (QTd) was defined as the minimum QT interval subtracted from the maximum. The Tp-e interval was defined as the difference between the QT and the QT peak time period. QTd and Tp-e intervals were calculated for all patients before and after exercise testing and differences between groups were compared. At peak exercise, QTd and cQTd showed a significant increase in comparison to baseline values in the group of patients with myocardial bridges. Significant increases were also found with exercise in the Tp-e, cTp-e durations and Tp-e/QT ratio of the MB patient group in comparison to the baseline values. On the other hand, significant differences in QTd, cQTd, Tp-e, cTp-e intervals, and Tp-e/QT ratio during peak exercise in comparison with baseline values were not detected in the control group (p>0.05). Significant increases in QTd, cQTd, Tp-e and cTp-e intervals and Tp-e/QT ratio were detected in the MB patients during exercise testing.
- 1 January 2015
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 21, 2116-2124
Open AccessExercise-Induced Repolarization Changes in Patients with Isolated Myocardial Bridging
Although myocardial bridging (MB) is defined as an angiographic phenomenon with a benign course, it has also been associated with adverse cardiovascular events. The effects of exercise on myocardial repolarization in patients with MB were tested in this study, with Tp-e and Tp-e/QT repolarization indexes. A total of 50 patients in whom isolated MB was diagnosed at coronary angiography (CAG) (Group I) and 48 patients with normal CAG results (Group II) were included in this study. The participants underwent treadmill exercise stress testing according to the Bruce protocol. QT dispersion (QTd) was defined as the minimum QT interval subtracted from the maximum. The Tp-e interval was defined as the difference between the QT and the QT peak time period. QTd and Tp-e intervals were calculated for all patients before and after exercise testing and differences between groups were compared. At peak exercise, QTd and cQTd showed a significant increase in comparison to baseline values in the group of patients with myocardial bridges. Significant increases were also found with exercise in the Tp-e, cTp-e durations and Tp-e/QT ratio of the MB patient group in comparison to the baseline values. On the other hand, significant differences in QTd, cQTd, Tp-e, cTp-e intervals, and Tp-e/QT ratio during peak exercise in comparison with baseline values were not detected in the control group (p>0.05). Significant increases in QTd, cQTd, Tp-e and cTp-e intervals and Tp-e/QT ratio were detected in the MB patients during exercise testing.
- 1 March 2012
- Published by Elsevier in International Journal of Cardiology
- Vol. 155, S120-S121
PP-069 THE FACTORS AFFECTING RADIAL ACCESS IN TRANSRADIAL CORONARY ANGIOGRAPHY AND ANGIOPLASTY PROCEDURES
- 1 March 2012
- Published by Elsevier in International Journal of Cardiology
- Vol. 155, S120-S121
PP-069 THE FACTORS AFFECTING RADIAL ACCESS IN TRANSRADIAL CORONARY ANGIOGRAPHY AND ANGIOPLASTY PROCEDURES